Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Biofidelity logo — Transforming human health by developing innovative technolog...

Biofidelity

Transforming human health by developing innovative technologies that unleash the potential of genomics

Founded 2019 United Kingdom Cambridge, United Kingdom 73 employees Venture round Total: $60.25M Biotechnology, Health Care

General Information

Company Name Biofidelity
Founded Year 2019
Location United Kingdom Cambridge, United Kingdom
Employees 73
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Biofidelity. To contact Biofidelity, visit biofidelity.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biofidelity compare?

A PDF of Biofidelity and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biofidelity soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biofidelity

Biofidelity is a rapidly growing commercial-stage genomic technology company founded in 2019 and based in the United Kingdom. The company's slogan, "Transforming human health by developing innovative technologies that unleash the potential of genomics," reflects its dedication to bringing the benefits of precision medicine to patients worldwide. Their first product, ASPYRE-Lung, has been launched in the US, and they boast an extensive pipeline of novel products. Biofidelity has developed a novel molecular biology technology that enables genomic analysis for cancer diagnosis to be carried out locally, quickly, and far more cost-effectively. This innovation holds the potential to significantly impact the field of biotechnology and healthcare. Notably, Biofidelity secured a $24.00M Venture Round investment on 03 April 2024, with participation from prominent investors including Blue Yard Capital, Octopus Ventures, Longwall Ventures, and Agilent Technologies. This significant investment attests to the confidence and support the company has garnered within the industry.

Business keywords: Genomics, Precision Medicine, Cancer Diagnosis, Molecular Biology, Innovative Technologies, Commercial-stage, ASPYRE-Lung, Genomic Analysis, Medical Diagnostics, Precision Medicine, Clinical Genomics, Startup, Investment Opportunity

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $24.00M 4
Blue Yard Capital Octopus Ventures Longwall Ventures
Blue Yard Capital, Octopus Ventures +2
03 Apr 2024
Series A $23.00M 2
Octopus Ventures SBI Investment
Octopus Ventures, SBI Investment
01 Feb 2022
Series A $12.00M -
18 Aug 2020
Grant £500.00K -
10 Oct 2019
Seed Round £750.00K -
01 Jun 2019

Latest News

View All
April’s early-stage funding wrapup: Big month for healthtech and UK maintains its crown — Sifted
April’s early-stage funding wrapup: Big month for healthtech and UK maintains its crown
Sifted May 10, 2024

Biofidelity Alternatives & Competitors

View All Alternatives
Biofidelity vs
Mendelics
Mendelics Brazil

Análise genômica ao alcance de todos

154 employees
Biotechnology, Health Care
Biofidelity vs
Empire Genomics
Empire Genomics United States

The First Choice For Fluorescence In Situ Hybridization

Debt Financing
18 employees
Biotechnology, Health Care
Biofidelity vs
Pathway Pharmaceuticals
Pathway Pharmaceuticals

Innovative precision medicine for personalized cancer treatment through advanced molecular analysis...

Seed
11-50 employees
Biotechnology, Health Care
View all alternatives

FAQ About Biofidelity

Transforming human health by developing innovative technologies that unleash the potential of genomics
Biofidelity was founded in 2019.
Biofidelity is headquartered in Cambridge, United Kingdom.
Biofidelity operates in Biotechnology and Health Care. Its work centres on Genomics, Precision Medicine, Cancer Diagnosis and Molecular Biology.
Biofidelity has approximately 73 employees.
Biofidelity has completed 5 funding rounds, raising a total of $60.25M. The latest funding stage is Venture round.
Top alternatives and competitors to Biofidelity include Mendelics, Empire Genomics, Pathway Pharmaceuticals, Exai Bio, Signal Genetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biofidelity and Mendelics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biofidelity, https://bouncewatch.com/company/biofidelity, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes